Reports for SANDOZ CANADA INCORPORATED

Company Name
SANDOZ CANADA INCORPORATED

Shortage reports

Actual shortage:

35 (1%)

Anticipated shortage:

9 (0%)

Avoided shortage:

19 (1%)

Resolved:

2320 (97%)

2383

Discontinuation Reports

To be discontinued:

3 (2%)

Discontinued:

131 (96%)

Reversed:

2 (1%)

136

466 (18%)

3 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
HALOPERIDOL LA 100MG LIQUID Resolved 2022-11-16 2022-12-29 174904
HALOPERIDOL LA 100MG LIQUID Resolved 2025-08-15 2025-09-13 265318
HALOPERIDOL LA 100MG LIQUID Resolved 2018-09-30 2018-10-04 62723
HALOPERIDOL LA 100MG LIQUID Resolved 2023-12-19 2024-01-17 213813
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 1000UNIT SOLUTION Resolved 2024-01-23 2024-02-27 217049
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 1000UNIT SOLUTION Resolved 2021-01-18 2021-02-01 131827
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 1000UNIT SOLUTION Resolved 2023-01-19 2023-02-15 181686
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 1000UNIT SOLUTION Resolved 2023-01-31 2024-07-30 182837
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 1000UNIT SOLUTION Resolved 2021-07-05 2022-08-18 141775
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 1000UNIT SOLUTION Resolved 2022-09-01 2022-09-28 168474
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 1000UNIT SOLUTION Resolved 2023-07-10 2023-08-22 197978
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 1000UNIT SOLUTION Resolved 2022-11-28 2023-01-19 175989
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Resolved 2020-08-26 2020-09-08 122970
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Resolved 2023-10-10 2023-10-19 206707
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Resolved 2022-02-01 2023-01-19 154024
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Resolved 2022-09-09 2022-09-10 169023
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Resolved 2024-05-07 2024-05-18 227194
HYDROMORPHONE HP 10 10MG SOLUTION Resolved 2022-02-17 2022-03-15 155250
HYDROMORPHONE HP 10 10MG SOLUTION Resolved 2017-06-26 2017-07-05 13885
HYDROMORPHONE HP 10 10MG SOLUTION Resolved 2023-08-07 2023-08-15 201259
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ RANITIDINE 150MG TABLET Reversed 2020-06-17 2020-06-17 118175
SANDOZ RISPERIDONE 0.5MG TABLET Discontinued 2025-12-01 2025-12-02 272923
SANDOZ RISPERIDONE 3MG TABLET Discontinued 2026-04-15 2026-04-15 282885
SANDOZ RISPERIDONE 2MG TABLET Discontinued 2026-04-15 2026-04-15 282907
SANDOZ RISPERIDONE 2MG TABLET Discontinued 2026-04-15 2026-04-15 282904
SANDOZ RISPERIDONE 1MG TABLET Discontinued 2026-04-15 2026-04-15 282901
SANDOZ RISPERIDONE 3MG TABLET Discontinued 2026-04-15 2026-04-15 282882
SANDOZ RISPERIDONE 3.0MG TABLET Discontinued 2021-03-22 2021-03-22 136095
SANDOZ RISPERIDONE 1.0MG TABLET Discontinued 2021-08-19 2021-08-19 144338
SANDOZ RISPERIDONE 1MG TABLET Discontinued 2025-07-02 2025-07-03 261506
SANDOZ RISPERIDONE 0.25MG TABLET Discontinued 2026-04-15 2026-04-15 282898
SANDOZ RISPERIDONE 4MG TABLET Discontinued 2026-04-15 2026-04-15 282918
SANDOZ RIVASTIGMINE 6MG CAPSULE Discontinued 2025-06-25 2025-06-26 261105
SANDOZ RIVASTIGMINE 6MG CAPSULE Discontinued 2024-12-10 2024-12-11 245291
SANDOZ RIVASTIGMINE 1.5MG CAPSULE Discontinued 2024-12-10 2024-12-11 245288
SANDOZ RIVASTIGMINE 1.5MG CAPSULE Discontinued 2024-12-10 2024-12-11 245285
SANDOZ RIVASTIGMINE 4.5MG CAPSULE Discontinued 2024-12-10 2024-12-11 245282
SANDOZ RIVASTIGMINE 4.5MG CAPSULE Discontinued 2024-12-10 2024-12-11 245279
SANDOZ RIVASTIGMINE 3MG CAPSULE Discontinued 2024-12-10 2024-12-11 245276
SANDOZ RIVASTIGMINE 3MG CAPSULE Discontinued 2024-12-10 2024-12-11 245273

Showing 101 to 120 of 136